低俗怪谈

US Publisher: What if COVID Outbreak is Part of the Pentagon's Biowarfare Plan?_我的网站

欢乐颂

一 |     专题:精准营养产业大会 精准蛋白营养 赋能全生命周期健康 8月21日-23日,第二届精准营养产业大会汇聚两院院士、行业协会、上下游企业数百位代表,将蛋白营养推到了中国健康产业的舞台中央。

二 |   从政策端明确2030年优质蛋白占比过半的目标,到消费端全生命周期需求的集中爆发,再到产业端核心原料长期进口依赖的痛点,这场大会聚焦行业现状与问题,联合产学研用多方力量深入探寻解决方案,是中国蛋白产业向自主创新转型的标志性节点。    Pyongyang's assumptions with regard to Washington's potential role in the COVID-19 pandemic apparently stem from a bombshell report by professors Jeffrey D Sachs and Neil L Harrison, published in May 2022 by peer-reviewed multidisciplinary scientific journal, The Proceedings of the National Academy of Sciences of the United States of America (PNAS).,"Prof Jeffrey Sachs of Columbia University had spent two years as chairman of the Lancet Commission on COVID and recently published a major paper in the prestigious PNAS journal arguing that the virus was very likely artificial, also calling for an independent inquiry into its possible American origins, but virtually all western media outlets ignored his dramatic reversal," says Ron Unz, an American technology entrepreneur, political activist, writer and the publisher of the Unz Review.,On 27 May, Sachs and Harrison released an op-ed for Project Syndicate, arguing that US authorities suppressed inquiries into the role US scientific research institutions may have played in creating the conditions of the COVID pandemic. "Yet if the coronavirus did indeed come from a lab, US culpability is almost certain," the professors insisted, calling for independent probes "not only into the outbreak in Wuhan, China, but also into the relevant US scientific research, international outreach, and technology licensing in the lead-up to the pandemic.",According to Sachs and Harrison, "the full story of the outbreak could involve America’s role in researching coronaviruses and in sharing its biotechnology with others around the world." The professors pointed out that "US scientists who work with SARS-like coronaviruses regularly create and test dangerous novel variants" to develop drugs and vaccines against them. These experiments, also known as "gain-of-function" research, have been conducted for decades prompting concerns that one day they could lead to an accidental outbreak or end up in the wrong hands, the scholars highlighted.,"In June, [Sachs] went even further in his public statements at a Spanish think-tank, describing the COVID virus as probably having an American origin," notes Unz. "In my opinion, Prof Sachs is merely stating what many senior figures in the West quietly believe or suspect but have been unwilling to mention publicly.",Situation in UkraineUS Has Helped Support 46 Biological Labs in Ukraine Over Last Two Decades, Pentagon Says9 June, 17:19 GMT,An Accidental Leak or a Warfare Tool?,America's experiments with viruses and dangerous pathogens have triggered concerns in Russia and China over the past few years. On 13 May 2020, Russia's Minister of Foreign Affairs Sergei Lavrov drew attention to a "dense network" of US biolabs located "along the perimeter of the Russian Federation and near Chinese borders".,Earlier this year, Beijing urged Washington to disclose the information about the activities of at least 360 biolabs in the world, presumably run by the US.,Since 2001, Russia, China, and many other countries have advocated the creation of a verification mechanism within the framework of the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on their Destruction to ensure biosafety across the world. Nonetheless, the US was "about the only country" which has categorically opposed this proposal for roughly 20 years, Lavrov revealed in 2020.,"Over the past 70 years, America has invested an estimated $100Bln in developing the world's largest and longest-standing biowarfare program," says Unz.,Situation in UkraineWhat's Behind Washington's Denial of Biowarfare Weapons Programme in Ukraine?12 March, 15:50 GMT,The American publisher suggested that the US could be responsible for the COVID outbreak long before Sachs and Harrison did. Furthermore, Unz does not rule out that the pathogen was used as a deliberate biowarfare tool against China and, possibly, Iran by "elements of [the US] national security establishment, though without the direct knowledge or authorization of President Donald Trump.",There are a lot of unknowns about the mysterious pandemic which is believed to have come from the Huanan Seafood Market in Wuhan, China. For instance, neither a COVID-19 "patient zero" nor a "guilty bat" have been found, which means that SARS-CoV-2 may actually have been circulating among humans some time before the late 2019 Wuhan outbreak, according to CBS News.,In April 2020, ABC News broke the story that a special medical intelligence unit within the US Defense Intelligence Agency (DIA) in the second week of November 2019 produced a classified report warning about an "out-of-control disease epidemic" in the Wuhan area of China. It urged the US to protect its forces in Asia. Although a Pentagon spokesman officially denied the existence of that November report, Israel's broadcaster Channel 12 said the US had also shared the document in question with NATO and Israeli Defense Force (IDF).,It appears suspicious, according to Unz, that the DIA rushed to dub the mysterious disease an "epidemic" at a time when just a couple of dozen individuals were infected in Wuhan.,"It therefore appears that elements of the Defense Intelligence Agency were aware of the deadly viral outbreak in Wuhan more than a month before any officials in the Chinese government itself," Unz points out. "Furthermore, the New York Times and CNN have also promoted a major new research study just published in Science that found the first Wuhan infection probably occurred on 18 November 2019. This was after the secret DIA report had already been produced, but the American media has completely ignored the implications of this striking discrepancy.",Yet another strange coincidence was Donald Trump's appointment of Robert Kadlec as the top official for dealing with biological threats in 2017, the American writer says. Since the Nineties, Kadlec had been one of America’s leading biowarfare advocates.,"From January to August 2019, Kadlec’s department ran the 'Crimson Contagion' simulation exercise, involving the hypothetical outbreak of a dangerous respiratory viral disease in China, which eventually spreads to the United States, with the participants focusing on the necessary measures to control it in this country," Unz says, adding that before that China had suffered two inexplicable viral epidemics which hit its poultry and pork industry in 2018 and 2019, respectively.,Situation in UkraineUkraine Labs: Bioweapons Can be Used as Tool in US Low-Level War Against Russia, ex-DoD Analyst Says15 April, 12:51 GMT,History of Pentagon's Bio-warfare,Although the Pentagon's alleged responsibility for the COVID outbreak has yet to be examined and backed by solid evidence, one must admit that Washington is no novice where biological warfare is concerened.,The US was accused of using germ weapons against Korea during the Korean War (1950-1953) and China based on the testimony of at least 38 US military pilots.,In August 2021, Xinhua quoted witnesses and historians describing how the Pentagon used germ bombs in civilian areas in China and Korea to spread dozens of species of poisonous insects and germs.,And Havana leveled accusations against the Pentagon over the dengue epidemic in Cuba that contaminated 345,000 people in 1981 and an artificial outbreak of African swine fever (ASF) that led to the slaughter of 500,000 animals and inflicted considerable economic damage on the island nation in 1971. The US Department of Defense denied the allegations.,"Over the years highly regarded and fully mainstream American journalists and academics have published books and articles documenting America's extensive use of biowarfare during the Korean War and later as anti-food supply attacks against Cuba, East Germany, and other countries," notes Unz.,Recently, Russia's Ministry of Defense has revisited cases pertaining to the US history of biological warfare, while examining a trove of highly sensitive documents shedding light on the Pentagon's experiments with highly contagious pathogens in Ukraine. According to the MoD, the Pentagon's Defense Threat Reduction Agency (DTRA) division ran a network of biological labs in Ukraine with the aim of inflicting damage on Russia's people and economy.,"I'm certainly aware of the Russian Ministry of Defense public claims regarding the Pentagon's involvement in Ukrainian biolabs, and the preparation of possible biowarfare attacks against Russia," says Unz. "I don't have any special knowledge of this issue, but the apparent public admission by [Undersecretary of State] Victoria Nuland at a US Senate hearing convinced me that there was a high likelihood that these Russian accusations were correct.",Unz argues that "American military plans for biowarfare attacks against Russia dramatically increase the likelihood that similar measures had been prepared against China and Iran, and perhaps actually carried out by rogue elements of the Trump Administration." Although US secretive biological programs and the Pentagon's overseas biowarfare labs have been triggering further suspicions, the topic still remains largely neglected and suppressed by western mainstream media.。  作为大会唯一企业承办方,飞鹤正式发布蛋白原料品牌“智纯FURIMMO”,以十余年深耕的底层技术、全品类原料产能与开放的产业生态,亮出了“蛋白科技专家”的硬实力。  当“补蛋白”进入精准时代,产业逻辑已从“补量”转向“提质”  事实上,蛋白消费的增长从来不是简单的“量的增加”。  据中国营养保健食品协会数据,2026年国内蛋白粉整体市场规模突破387亿元,同比增长 17.99%,消费者年均摄入量较2023年增长68%,增速大幅领先传统保健食品品类。

三 |   中国营养学会理事长杨月欣在圆桌论坛上指出,我国居民蛋白质并非总量不足,核心问题是结构失衡。乳蛋白作为氨基酸评分满分的优质蛋白,在国人膳食蛋白来源中占比仅2%,远低于欧美国家20%—25%的水平。城市人群动物蛋白占比偏高、豆类摄入不足,农村地区优质蛋白来源有限,国民蛋白营养的核心矛盾已从“补够量”转向“提品质”。

四 |   更核心的变化还发生在需求端,消费人群与场景的分化正在加速。  汤臣倍健副董事长梁水生观察到,蛋白消费早已转向全生命周期大众营养,例如儿童青少年生长发育、中青年运动健身与体重管理、中老年肌肉衰减预防与慢病养护,不同人群的需求高度分化。  数据显示,全球乳清蛋白市场以约12%的年复合增长率快速扩张,机构预测2026年将达122万吨,增量主要来自运动营养、婴配粉、老龄化特医等赛道。在中国市场,这一趋势同样明显,2026年中国蛋白粉行业报告显示,2025年国内蛋白粉整体市场规模突破387亿元,同比增长18%,蛋白消费正从“小众运动补剂”走向“全民日常营养”。  与此同时,GLP-1类减重药的爆发式增长,进一步推高蛋白需求热潮。GLP-1药物通过抑制食欲、延缓胃排空帮助使用者减重,医生通常会建议补充高蛋白以维持健康。因此目前全球超5000万用药人群需补充乳清蛋白以防肌肉流失。摩根士丹利预测,2030年全球GLP-1用药人群将达7000万。  全球蛋白消费的结构性扩容与减重药的短期催化叠加,共同推高了蛋白原料的全球供需缺口。与会专家共识,面对日益增长的蛋白营养细分需求,产业必须从“通用蛋白”转向“功能化、场景化”的精准供给,这对于产业前端的原料生产和产品创新提出了全新的要求。  为什么高端蛋白原料始终是“卡脖子”环节?  中国工程院院士任发政进一步点明,蛋白质没有人体长期储备库,每日“拆旧建新”的代谢速率个体差异极大,且蛋白质的生理活性不只取决于氨基酸组成,更取决于空间结构的完整性。  这意味着,高品质、高活性、分功能的蛋白原料,是精准营养真正落地的底层基础。  需求端的高速增长,反衬出供给端的深层困境。长期以来,高端乳蛋白原料的技术、产能、定价权均掌握在海外企业手中。  以欧美乳蛋白产业为例,其建立在成熟的奶酪工业之上。而奶酪作为居民日常消费刚需,其生产副产物乳清液再加工提取乳清蛋白、酪蛋白,形成“奶酪消费—副产物利用—深加工原料”的完整闭环,原料成本低、产业协同性强。  但中国乳业的消费结构以液态奶为主,干乳制品占比不足7.3%,缺乏大规模奶酪产业基础,天然缺少乳蛋白深加工的副产物来源。高端蛋白分离设备、核心萃取材料也长期依赖进口,从工艺到装备的“卡脖子”,让国产蛋白深加工始终停留在初级加工层面,难以向高附加值功能原料升级。

五 |   中国奶业协会数据显示,我国乳清蛋白进口依赖度超90%,乳铁蛋白进口依存度达95%。价格波动直接冲击着全产业链,近两年浓缩乳清蛋白原料成本累计上涨108%,分离乳清蛋白涨幅达139%。  香驰控股董事长刘兆辉表示,蛋白产业正在从“卖原料”向“卖功能”转型,消费者不再只问含量、价格,更问应用场景、功能效果。

六 | 但如果核心原料、底层技术受制于人,功能创新与场景拓展就无从谈起。  自研技术打底,飞鹤成为中国乳蛋白“破局者”  基于此,飞鹤率先构建起自主可控的乳蛋白全产业链体系。通过攻克膜分离、色谱纯化等关键核心技术,不仅实现了乳铁蛋白等高附加值原料的规模化量产,更将进口依赖度大幅降低。  飞鹤副总裁、研究院院长张旭光坦言,一罐婴配粉中,生牛乳基粉仅占20%—30%,50%以上是乳清蛋白、乳铁蛋白、α-乳白蛋白等功能配料。进口原料储运周期长达8个月以上,新鲜度流失、蛋白活性下降,对肠道娇嫩的婴幼儿并不友好。从2011年启动乳铁蛋白研发开始,飞鹤走上了核心原料自主攻关之路。  十余年投入数亿元研发经费,历经3000余次中试级实验、消耗30多万吨鲜奶,飞鹤独创全球领先的“乳蛋白鲜萃活性工艺”,通过膜分离、层析萃取、定向酶解等低温物理技术,直接从自有牧场鲜奶中一次提取蛋白,最大程度保留天然结构与生物活性。

七 |   截至2026年,飞鹤已实现16种核心乳原料100%自研自产,深加工设备国产化率超80%,核心过滤萃取材料100%国产化。

八 | 同时布局黑龙江、内蒙古、宁夏三大深加工基地,日处理鲜奶能力达3000吨,建成国内首条高纯度α-乳白蛋白智能化生产线,跻身全球万吨级乳蛋白供应商行列。  技术与产能的硬实力,吸引了产业链上下游的广泛合作,也成为飞鹤深加工能力的最好印证。  本次大会上,飞鹤正式推出专业蛋白原料品牌“智纯 FURIMMO”,定位“鲜萃蛋白科技专家”,面向全行业提供乳蛋白、乳脂肪、乳渗透物三大类原料产品,以及定制化解决方案。

九 |   “智纯”一口气联合多家企业发布五款复合功能预混料,例如与山东御馨生物联合研发酸肽 CPP 双蛋白原料,以及同挪威阿克海洋生物推出酪蛋白包埋磷虾油创新成果等等,突破磷虾油剂型限制,拓展至乳粉、饮品等多元应用,兼具营养、保鲜、吸收、功效四重协同。  在B端原料供应层面,飞鹤智纯已进入立高、雀巢、蜜雪冰城、蒙牛、汤臣倍健、康比特等头部品牌的供应链,应用覆盖食品加工、运动营养、特医食品、中老年营养等多元场景。  大会现场,飞鹤更与康比特、西子健康、微康、百合生物、京东等企业达成战略合作,共建国产蛋白供应链生态。  汤臣倍健副董事长梁水生评价,飞鹤在乳业深加工上的突破,对中国乳蛋白产业的深入发展有极大推动作用。  同时,大会现场,中国营养学会牵头、飞鹤等机构联合编写的《精准营养技术与产业创新白皮书2.0》也正式发布。  与1.0版侧重科研前沿不同,2.0版首次将“精准原料”作为核心更新,明确“物质结构清晰、有效成分清晰、功能靶点清晰、人体作用效率清晰”的四大标准。在飞鹤等企业的推动下,精准营养不再是悬浮的学术概念,而是有了可落地的原料底座。  在中国大健康产业升级的浪潮中,核心原料自主是产业安全的压舱石,也是创新发展的源动力。飞鹤以技术换道超车的实践,不仅为中国乳蛋白产业打破了海外垄断,更以开放的产业生态,为整个精准营养行业的高质量发展注入了内生动力,最终指向“健康中国”的宏大目标——让每一个年龄段的中国人,都能享受到精准、鲜活、高品质的蛋白营养。  新浪声明:所有会议实录均为现场速记整理,未经演讲者审阅,新浪网登载此文出于传递更多信息之目的,并不意味着赞同其观点或证实其描述。责任编辑:李思阳。

Current article:http://ek8a.foucaorengtunzhuaikuowang.cyou/list_j926/cq1ip.html

Published on:00:57:58


关于我的网站 | 我的网站动态 | 联系我们 | 法律声明 | 我的网站员工 | 我的网站邮箱 | 网站地图

我的网站版权所有